[1]
“Challenges in Diagnosis and Management of Cutaneous Adverse Drug Reaction”, Nepal J Dermatol Venereol & Leprol, vol. 18, no. 1, pp. 1–2, Oct. 2020, doi: 10.3126/njdvl.v18i1.30353.